About this item:

239 Views | 219 Downloads

Author Notes:

Yoland Smith, Yerkes Regional Primate Center, Emory University, 954 Gatewood Road NE, Atlanta, GA 30341.

We thank Jean-François Paré and Isabelle Deaudelin for their excellent technical assistance.

Subject:

Research Funding:

This research was supported by the Canadian Foundation of Parkinson’s Disease; and the Fonds de la Recherche en Santé du Québec; as well as by the Department of Neurology and the Yerkes Primate Center of Emory University.

Maryse Paquet holds a studentship from the Medical Research Council of Canada.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • excitotoxicity
  • Parkinson's disease
  • substantia nigra
  • ventral tegmental area
  • dopamine
  • glutamate receptor
  • METHYL-D-ASPARTATE
  • VENTRAL TEGMENTAL AREA
  • RAT SUBSTANTIA-NIGRA
  • AMINO-ACID RECEPTOR
  • CENTRAL-NERVOUS-SYSTEM
  • SUBTHALAMIC NUCLEUS
  • BASAL GANGLIA
  • MESSENGER-RNAS
  • CELLULAR-LOCALIZATION
  • PARKINSONS-DISEASE

AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: An immunohistochemical and in situ hybridization study

Tools:

Journal Title:

Journal of Neuroscience Nursing

Volume:

Volume 17, Number 4

Publisher:

, Pages 1377-1396

Type of Work:

Article | Final Publisher PDF

Abstract:

The objective of the present study was to analyze the cellular and subcellular localization of ionotropic glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey. This was achieved by means of immunohistochemistry at light and electron microscopic levels and in situ hybridization histochemistry. Colocalization studies show that nearly all dopaminergic neurons in both the ventral and dorsal tiers of the substantia nigra compacta (SNc-v, SNc-d) and the ventral tegmental area (VTA) are immunoreactive for AMPA (GluR1, GluR2/3, and GluR4) and NMDAR1 receptor subunits, but not for NMDAR2A/B subunits. The immunoreactivity of the receptor subunits is associated mainly with perikarya and dendritic shafts. Apart from the intensity of immunolabeling for the GluR4 subunit, which is quite similar for the different groups of midbrain dopaminergic neurons, the overall intensity of immunostaining for the other subunits is higher in the SNc-v and SNc-d than in the VTA. In line with these observations, in situ hybridization shows that the average level of labeling for the GluR2 and NMDAR1 subunit mRNAs is significantly higher in the SNc-v than in the VTA, and for the NMDAR1 subunit, higher in the SNc-v than in the SNc-d. In contrast, no significant difference was found for the level of GluR1 mRNA labeling among the three groups of midbrain dopaminergic neurons. At the subcellular level in the SNc-v, AMPA (GluR1 and GluR2/3) and NMDAR1 receptor subunit immunoreactivity is preferentially associated with the postsynaptic densities of asymmetric synapses, but occasionally some immunoreactivity is found along nonsynaptic portions of plasma membranes of dendrites. A small number of preterminal axons, axon terminals, and glial cell processes are also immunoreactive. Our observations indicate that the different groups of midbrain dopaminergic neurons in primates exhibit a certain degree of heterogeneity with regard to the level of expression of some ionotropic glutamate receptor subunits. The widespread neuronal and glial localization of glutamate receptor subunits suggests that excitatory amine acids may act at different levels to control the basal activity and, possibly, to participate in the degeneration of midbrain dopaminergic neurons in Parkinson's disease.

Copyright information:

Copyright © 1997 Society for Neuroscience

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote